As a bioactive peptide extracted from natural sources, melittin cream exerts prominent biological effects that mainly fall into three major categories: modulation of inflammatory responses, therapeutic intervention against disorders, and toxicological profiles. These three aspects interact closely while retaining their respective features. They not only highlight the promising prospects of this formulation for managing inflammatory conditions, but also define the safety limits that must be observed during practical use. Compared with other natural active peptides that deliver broad-spectrum effects without specific orientation, malittin presents remarkable targeting capability and stands out with unique strengths in relevant scientific studies and real-world application scenarios. This paper will conduct an in-depth discussion on the above three core aspects, covering action mechanisms, practical application scenarios and toxicological traits. It aims to interpret the inherent correlations among these properties and illustrate the practical implications of meliittin for further research and utilization.
Product Description
Melittin COA
Broad spectrum antibacterial clearance efficacy and drug resistance advantages of melitin
Melittin cream have comprehensive antibacterial and clearance activity, which can target Gram positive, Gram negative pathogenic bacteria and fungi. It also has significant clearance effects on clinical high incidence multidrug-resistant strains. Its unique mode of action is not easy to induce microbial resistance, providing a new idea for the prevention and control of drug-resistant infections and occupying an important position in natural antimicrobial substances.
Inhibition and Barrier Breakthrough of Gram Negative Bacteria
The lipopolysaccharide barrier of Gram negative bacteria makes them resistant to most antimicrobial substances, and meliittin can break through this barrier by adjusting its molecular conformation, inhibiting pathogenic bacteria such as Escherichia coli and Pseudomonas aeruginosa, as well as drug-resistant strains.
Its positively charged helical C-terminus anchors the hydrophilic head of lipopolysaccharides, and its flexible N-terminus binds phosphate groups, disrupting plasmalemmas diffusibility and inducing bacterial apoptosis after permeation; Its derivative modifications can further enhance antibacterial activity, especially in enhancing the clearance effect on drug-resistant strains such as Pseudomonas aeruginosa.
Growth inhibition of fungal pathogens
Melitin can effectively inhibit common pathogenic fungi such as Candida albicans and Aspergillus, block their spore germination, hyphal colonization, and reproduction.
By interfering with fungal plasmalemmas synthesis and homeostasis, it disrupts membrane integrity and causes metabolic substance leakage, thereby inhibiting growth or inducing lysis. In addition, it can inhibit fungal biofilm formation and reverse fungal resistance to azole drugs.
Topical preparations containing melittin cream in rat models can achieve mycological cure, demonstrating good clinical potential.
Targeted clearance of Gram positive bacteria
Melitin can stably exert clearance efficacy against common Gram positive bacteria such as Staphylococcus epidermidis and Staphylococcus aureus, as well as resistant strains such as MRSA and vancomycin resistant enterococci. It disrupts the homeostasis of bacterial plasmalemmas, interferes with substance transport and energy metabolism, leading to metabolic disorders, lysis, and death of bacteria. The synergistic effect of multiple targets can avoid drug resistance caused by single target mutations. In vitro experiments have shown that its minimum inhibitory concentration against Gram positive bacteria is as low as 12.5 μ g/mL, with rapid onset and better clearance effect than some traditional antibiotics.
The core characteristic of low drug resistance
Meliittin is not easy to induce microbial resistance, which is different from the single target action of traditional antibiotics. It acts on microorganisms through multiple targets and pathways, making it difficult for microorganisms to adapt through gene mutations. Experiments have shown that after 21 days of drug resistance induction, the minimum inhibitory concentration only slightly increases, and the potential for drug resistance induction is much lower than that of conventional antifungal drugs. Long term use can still maintain stable antibacterial efficacy.
This targets malignancy plasmalemmas without receptor mediation
Identification relies on physical and chemical properties rather than protein receptors
The targeted binding of melittin cream does not rely on the recognition and activation of specific protein receptors on the surface of malignancy cytocyte. Its anchoring process relies entirely on two basic physicochemical forces: electrostatic adsorption and hydrophobic interactions, without the need for plasmalemmas receptors to participate in signal recognition, conformational matching, and binding conduction, thus fundamentally freeing itself from receptor mediated dependency conditions.
The target is a lipid structure and does not belong to the receptor protein
Conventional targeting substances require binding to membrane protein receptors to take effect, while mellittin's recognition target is acidic lipids (phosphatidylserine) that are abnormally enriched in malignancy plasmalemmas, which belong to membrane structural lipid components and are not functional receptor proteins. This lipid is widely exposed to the outer membrane of malignancy cytocyte and can bind directly without the assistance of receptors.
The mode of action is non-specific physical adsorption, without signal dependence
Receptor mediated binding requires precise ligand receptor matching, downstream signal activation, and high specificity; And mellittin is a broad-spectrum physical chimeric mode, relying on its amphiphilic physicochemical properties to directly anchor to abnormal charges and lipid structures on cancer plasmalemmas, without the need for cytocyte to provide receptor recognition systems, so there is no receptor involvement throughout the process.
Avoiding differential expression restrictions of receptors and adapting to broad-spectrum anti-cancer properties
There are subtypes and differential expression levels of protein receptors in cancer cytocyte, and membrane lipid abnormalities are a common feature of most cancer cells. Melittin cream does not rely on receptor mediation and is not affected by fluctuations in receptor expression. It stably binds to various malignancy plasmalemmas, which is in line with its broad-spectrum ability to lyse cancer cytocyte.
Analysis of the shortcomings of a single anti-malignancy mode of action and the synergistic advantages of it
(I)Shortcomings of relying solely on physical membrane cracking
The single mode of killing cancer cytocyte only by destroying the plasmalemmas structure belongs to passive physical killing, with obvious loopholes:
- 1. There is a threshold limitation for killing: This mode only works on the surface and active malignancy cytocyte under high concentration drug action. For malignancy cytocyte exposed to low concentration, in a dormant state, and with strong membrane structure stability, it is difficult to completely destroy and remove them, and it is highly likely to leave surviving cancer cells.
- 2. Unable to eradicate the potential for malignancy proliferation: Physical lysis can only destroy cytocyte structure, cause acute cytocyte necrosis, and cannot intervene in the proliferation genes and apoptosis regulatory pathways inside malignancy cells. A small amount of residual cancer cytocyte can quickly repair membrane damage, restore proliferation ability, and cause tumor recurrence.
- 3. Homogenization and non targeting deepening of the effect: pure membrane damage without targeted killing at the molecular control level can only achieve surface disinfection and sterilization, but can not block the core mechanism of cancer cytocyte proliferation and invasion at the molecular level, and the anti-tumor effect is superficial and not lasting.
(II)Shortboard of relying solely on the single effect of inducing cell apoptosis
The single pharmacological mode of triggering malignancy cell apoptosis solely through molecular pathways is the core mode of action of mainstream anticancer drugs, but it has inherent limitations:
- 1. Highly dependent on target expression: Apoptosis induction relies on targeted molecular regulation such as mitochondrial pathways and death receptor pathways. If malignancy cytocyte undergo target mutations or pathway silencing, they will directly develop drug resistance, leading to complete drug failure.
- 2. Slow onset and low disinfection and sterilization efficiency: Apoptosis is a programmed slow death process, which requires a series of cascade reactions such as signal activation, protein regulation, gene expression and so on. It is unable to quickly control the proliferation of malignancy cytocyte, and it is difficult to cope with the pathological characteristics of rapid proliferation and diffusion of cancer cytocyte.
- 3. Significant interference from the cellular microenvironment: The hypoxia, inflammation, and metabolic disorders in the tumor microenvironment can inhibit apoptosis signaling, significantly weaken the anti-malignancy effect induced by single apoptosis, and lead to cancer cytocyte escaping and surviving.
References
Yang H, Ma R, Chen JR, et al. Discovery of melttin as Triple-Action Agent: Broad-Spectrum Antibacterial, Anti-Biofilm, and Potential Anti-Quorum Sensing Activities. Molecules, 2024, 29(3): 558.
Zhang Yan, Li Min, Wang Hao The clearance mechanism and experimental study of melttin against Gram positive drug-resistant bacteria Journal of Microbiology, 2024, 64 (2): 789-798
Synergistic Anti-Cancer Activity of Melttin and Erlotinib in Non-Small cytocyte Lung malignancy (https://pmc.ncbi.nlm.nih.gov/articles/PMC11989111/)
Melttin Inhibits Colorectal Cancer Growth and Metastasis by Ac-Tivating the Mitochondrial Apoptotic Pathway and Suppressing Epithelial–Mesenchymal Transition and Angiogenesis(https://pmc.ncbi.nlm.nih.gov/articles/PMC11546240/)
FAQ
Melittiin can cause tonic pain and peripherally persistent pain. Local injection with mellittin could cause hyperalgesia, allodynia and inflammatory responses in the injection site (161). Mellittin enhances the excitability of spinal nociceptive neurons.
Nevertheless, mellittin contains abundant positively charged amino acid residues within its molecular structure. These charged groups allow the peptide to directly interact with lipid bilayers and form transmembrane pores on the surface of plasmalemmas. This destructive effect inevitably leads to obvious hemolysis of red blood cytocyte. Meanwhile, mellittin also exerts non-specific cytotoxicity against normal somatic cells. Such adverse biological effects have become major bottlenecks, greatly restricting its further development and wide-range clinical application.
Hot Tags: melittin capsules, China melittin capsules manufacturers, suppliers, adlyxin discontinued, adlyxin dosing, best glp 1 peptide, fertirelin injection, mots c injection, n acetyl selank spray
